These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Microselectron HDR--its use in oesophageal and bronchial work and how it affects the therapy radiographer. Farrell CJ Radiogr Today; 1989 Feb; 55(621):16-8. PubMed ID: 2480143 [No Abstract] [Full Text] [Related]
5. [The role of endoluminal curietherapy in the treatment of esophageal carcinoma]. Milani F Ann Ital Chir; 1993; 64(6):647-9. PubMed ID: 7521598 [No Abstract] [Full Text] [Related]
6. [Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in esophageal cancer]. Patonay P; Naszály A; Mayer A Strahlenther Onkol; 2007 Feb; 183(2):94-8. PubMed ID: 17294114 [TBL] [Abstract][Full Text] [Related]
7. Brachytherapy for oesophageal cancer. Sur RK; Levin CV S Afr J Surg; 1995 Jun; 33(2):49-51. PubMed ID: 8545723 [No Abstract] [Full Text] [Related]
10. [Palliative treatment in patients with oesophagus carcinoma]. Siersema PD; Verschuur EM; Homs MY; van der Gaast A; Eijkenboom WM; Kuipers EJ Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2775-82. PubMed ID: 16385829 [TBL] [Abstract][Full Text] [Related]
11. Palliation of esophageal cancer: there is no clear winner. Shakespeare TP Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):849-50; author reply 850. PubMed ID: 12573775 [No Abstract] [Full Text] [Related]
12. Stent vs. brachytherapy: does life expectancy help you decide? Wallace MB Gastrointest Endosc; 2005 Sep; 62(3):341-3. PubMed ID: 16111948 [No Abstract] [Full Text] [Related]
13. The value of high-dose-rate microsource brachytherapy in the treatment of oesophageal carcinoma. Sur RK; Levin CV; Donde B S Afr Med J; 1997 Jan; 87(1):81-2. PubMed ID: 9063334 [No Abstract] [Full Text] [Related]
14. [Results of multimodal treatment combined with remote after-loading system (RALS) for malignant esophageal cancer]. Iwasa M; Kogoshi S; Toki T; Omori Y; Iwasa M; Yamamoto A; Inoue A; Maeda H; Kume M; Kusume K; Toshimitsu Y Nihon Kyobu Geka Gakkai Zasshi; 1997 Mar; 45(3):350-2. PubMed ID: 9235332 [No Abstract] [Full Text] [Related]
15. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928 [TBL] [Abstract][Full Text] [Related]
16. Intraluminal high dose rate brachytherapy of tumorous esophageal stenoses. Dvorak J; Petera J; Kabelac K; Melichar B; Voboril R; Filip S; Vosmik M; Hulek P Hepatogastroenterology; 2006; 53(71):702-4. PubMed ID: 17086872 [TBL] [Abstract][Full Text] [Related]
17. Endocavitary radiotherapy in carcinoma oesophagus. Jha AK; Prasiko G; Mod H; Chaurasia PP; Srivastava E JNMA J Nepal Med Assoc; 2006; 45(161):173-7. PubMed ID: 17160092 [TBL] [Abstract][Full Text] [Related]
18. [Treatment of locally advanced esophageal cancer by combined intralumenal brachytherapy and external beam radiotherapy]. Mileusnić D; Durbaba M; Vucićević S; Stanković J; RadosevićJelić Lj; Pekmezović T Srp Arh Celok Lek; 1995; 123(9-10):254-7. PubMed ID: 17974443 [TBL] [Abstract][Full Text] [Related]
19. Esophageal cancer. A prospective phase II study of concomitant-boost external-beam chemoradiation with a top-up endoluminal boost. Brunner TB; Rupp A; Melzner W; Grabenbauer GG; Sauer R Strahlenther Onkol; 2008 Jan; 184(1):15-22. PubMed ID: 18188518 [TBL] [Abstract][Full Text] [Related]